Periorbital contact eczema;Periorbitale kontaktekzeme

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 11, 2005, Pages 853-855

  Worm, M ^a   Sterry, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Contact allergy; Eczema; Ingredients

Indexed keywords

ALLERGEN; CORTICOSTEROID; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; PIMECROLIMUS; TACROLIMUS;

AUTOIMMUNE DISEASE; CONTACT DERMATITIS; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE MIGRATION; MEDIATOR RELEASE; ORBIT DISEASE; PATCH TEST; PERIORBITAL CONTACT ECZEMA; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION;

DERMATITIS, CONTACT; EYE DISEASES; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 29144436428     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858796     Document Type: Review

References (19)

1. Guin JD. Eyelid dermatitis: a report of 215 patients. Contact Dermatitis 2004; 50 (2): 87-90
2. Schnuch A, Lessmann H, Geier J et al. Contact allergy to fragrances: frequencies of sensitization from 1996 to 2002. Results of the IVDK*. Contact Dermatitis 2004; 50 (2): 65-76
3. Goossens A, Decraene T, Platteaux N et al. Glucosides as unexpected allergens in cosmetics. Contact Dermatitis 2003; 48 (3): 164-166
4. Goebler M, Trautmann A, Voss A et al. Differential and sequential expression of multiple chemokines during elicitation of allergic contract hypersensitivity. Am J Pathol 2001; 158: 431-440
5. Robert C, Kupper TS. Inflammatory skin diseases, T cells and immune surveillance. New Engl J Med 1999; 341: 1817-1828
6. Girolomoni G, Sebastiani S, Albanesi C et al. T cell subpopulations in the development of atopic and contact allergy. Curr Opin Immunol 2001; 13: 733-737
7. Buckley CD, Pilling D, Lord JM et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001; 22: 199-204
8. Aberer W, Komericki P, Uter W et al. Epidemiologische Überwachung von Kontaktallergenen. Der "Monitorblock" des IVDK. Der Hautarzt 2003; 8: 741-749
9. Hoffmann K, Auer T, Stucker M et al. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone. J Eur Acad Dermatol Venereol 1998; 10 (2): 137-142
10. Kecskés A, Heger-Mahn D, Kleine Kuhlmann R et al. Comparison of the local and systemic side effects of methyprednisolone aceponate and mometasone furoate applied as ointment with equal antiinflammatory activity. J Am Acad Dermatol 1993; 29: 576-580
11. Kerscher MJ, Korting HC. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis. Skin Pharmacol 1992; 5: 77-80
12. Korting HC, Unholzer A, Schäfer-Korting M et al. Different skin thinning potential of equipotent medium strength glucocorticoids. Skin Pharmacol Appl Skin Physiol 2002; 15: 71-84
13. Lévy J, Gassmüller J, Schröder G et al. Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 1994; 7: 231-236
14. Mills CM, Marks R. Side effects of topical glucocorticoids. In: Korting HC, Maibach HI (Hrsg). Topical glucocorticoids with increased benefit/risk ratio Curr Problems Dermatol, 1993; 21: 122-131
15. Schäfer-Korting M, Korting HC, Kerscher MJ et al. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids. Clin Pharmacol Ther 1993; 54: 448-456
16. Tan CY, Dykes P, Marks R. Ultrasound detection of corticosteroid induced dermal atrophy. Brit J Dermatol 1980; 102: 732
17. Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005; 211 (2): 174-187
18. Herbst RA, Uter W, Pirker C et al. Allergic and non-allergic periorbital dermatitis: patch test results of the Information Network of the Departments of Dermatology during a 5-year period. Contact Dermatitis 2004; 51 (1): 13-19
19. Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113 (5): 832-836